Compounds > 2-amino-5-phosphonovalerate
Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Experimental Spinal Cord Ischemia

2-amino-5-phosphonovalerate has been researched along with Experimental Spinal Cord Ischemia in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishi, H1
Nakatsuka, T1
Takeda, D1
Miyazaki, N1
Sakanaka, J1
Yamada, H1
Yoshida, M1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Experimental Spinal Cord Ischemia

ArticleYear
Hypothermia suppresses excitatory synaptic transmission and neuronal death induced by experimental ischemia in spinal ventral horn neurons.
    Spine, 2007, Dec-01, Volume: 32, Issue:25

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anterior Horn Cells; Cel

2007